2-Pyridinecarboxamide, N-[1-[2-[(cyclopropylsulfonyl)amino]-4-thiazolyl]cyclopropyl]-5-(6-ethoxy-2-pyrazinyl)- manufacturers
- CTPS1-IN-1
-
- $175.00
-
2026-05-12
- CAS:2341943-12-0
- Purity: 99.46%
- Supply Ability: 10g
|
| | 2-Pyridinecarboxamide, N-[1-[2-[(cyclopropylsulfonyl)amino]-4-thiazolyl]cyclopropyl]-5-(6-ethoxy-2-pyrazinyl)- Basic information |
| | 2-Pyridinecarboxamide, N-[1-[2-[(cyclopropylsulfonyl)amino]-4-thiazolyl]cyclopropyl]-5-(6-ethoxy-2-pyrazinyl)- Chemical Properties |
| density | 1.53±0.1 g/cm3(Predicted) | | pka | 6.99±0.20(Predicted) | | form | Solid | | color | White to off-white |
| | 2-Pyridinecarboxamide, N-[1-[2-[(cyclopropylsulfonyl)amino]-4-thiazolyl]cyclopropyl]-5-(6-ethoxy-2-pyrazinyl)- Usage And Synthesis |
| Uses | CTPS1-IN-1 (compound R80) is a CTPS1 inhibitor. CTPS1-IN-1 has the potential to research cancer (such as promoting vascular injury or surgical recovery) and immune system diseases (such as rejection of transplanted cells and tissues, transplant-related diseases or disorders, allergies, and autoimmune diseases)[1]. | | References | [1] Andrew Novak, et al. Preparation of substituted sulfonamidothiazoles as CTRS1 inhibitors. Patent WO2019106146A1. |
| | 2-Pyridinecarboxamide, N-[1-[2-[(cyclopropylsulfonyl)amino]-4-thiazolyl]cyclopropyl]-5-(6-ethoxy-2-pyrazinyl)- Preparation Products And Raw materials |
|